Sharekhan

Gufic BioSciences Ltd

Wed 21/05/2025,15:56:14 NSE: GUFICBIO

₹ 374.85 -7.85 (-2.05%)
BUY NOW Buy Gufic BioSciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Gufic BioSciences Ltd

Wed 21/05/2025,16:1:0

Gufic BioSciences Ltd

Wed 21/05/2025,15:56:14 | NSE : GUFICBIO

₹ 374.85-7.85 (-2.05%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 383.50

Previous Close

₹ 382.70

Volume

58559

Mkt Cap ( Rs. Cr)

₹3758.90

High

₹ 390.65

Low

₹ 372.35

52 Week High

₹ 504.25

52 Week Low

₹ 278.00

Book Value Per Share

₹ 57.26

Dividend Yield

0.02

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Gufic BioSciences Ltd

Your Vote -

Buy

84.00%

Hold

12.00%

Sell

4.00%

84.00%

25 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

374.85

1930

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

1930

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Gufic BioSciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Gufic BioSciences Lt - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    2 May 2025, 6:52PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Resignation of Cost Auditor is attached h

  • Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    2 May 2025, 6:51PM GUFIC BIOSCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A

  • Gufic BioSciences Lt - Resignation

    2 May 2025, 6:50PM Gufic Biosciences Limited has informed the Exchange regarding Resignation of M/s. Kale & Associates, Cost Accountants as the Cost Auditor of the comp

  • Gufic BioSciences Lt - Disclosure under SEBI Takeover Regulations

    24 Apr 2025, 3:50PM Jayesh Choksi (For and on behalf of Promoter Group/ PACs of the Company) has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of

  • Gufic BioSciences Lt - Updation Of Contact Details Of Registrar And Share Transfer Agent ('RTA') Of The Company

    18 Apr 2025, 4:36PM Intimation for Updation of Contact Details of Registrar and Share Transfer Agent (\RTA\) of the Company is attached herewith.

  • Gufic BioSciences Lt - Updates

    18 Apr 2025, 4:33PM Gufic Biosciences Limited has informed the Exchange regarding updation of Contact Details of Registrar and Share Transfer Agent ( RTA ) of the Company

  • Gufic BioSciences Lt has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    15 Apr 2025, 5:31PM As of March 2025, 72.51% is owned by Indian Promoters and 27.49% by Public. <p align=justify> Top five Promoters holding highest number of shares of G

  • Gufic BioSciences Lt - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    14 Apr 2025, 7:04PM Gufic Biosciences Limited has informed the Exchange about Intimation of Appeal filed against Assessment Order passed by the Assessment Unit, Income Ta

  • Gufic BioSciences Lt - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2025, 11:55AM Gufic Biosciences Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

  • Gufic BioSciences Lt - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2025, 11:54AM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025 is attached herewith

  • Gufic BioSciences Lt - Trading Window-XBRL

    27 Mar 2025, 7:19PM Gufic Biosciences Limited has informed the Exchange about Closure of Trading Window

  • Gufic BioSciences Lt - Trading Window

    27 Mar 2025, 7:17PM Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations

  • Gufic BioSciences Lt - Action(s) taken or orders passed

    19 Mar 2025, 8:34PM Gufic Biosciences Limited has informed the Exchange about Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regu

  • Gufic BioSciences Lt - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    19 Mar 2025, 8:33PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    21 Feb 2025, 2:32PM Written Transcript of Earnings Conference Call is attached herewith.

  • Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates

    21 Feb 2025, 2:31PM Gufic Biosciences Limited has informed the Exchange about Transcript

  • Gufic receives NMPA China nod for Prilocaine API

    19 Jun 2023 , 11:58AM Gufic Biosciences gets NMPA approval for Prilocaine API

  • Gufic BioSciences

    7 Jun 2022 , 10:08AM Gufic Biosciences: Has launched a new drug delivery system - Dual Chamber Bags at affordable price first time in the India markets. The product launch is basis the collaboration with its European partner. The dual chamber bags come with a peelable aluminium foil allowing the storage of unstable drugs which needs reconstitution just before the administration to the patient. With the launch of this product Gufic aims to capture a major share of Rs 3000 cr lyophilized antibacterial market in India and hence is Positive, though we do not have a coverage on the stock.

  • Gufic Bio gets two patent certificates; stk gains

    6 Jun 2017 , 12:58PM Gufic Biosciences rises over 7% to Rs73.75, after receiving two patent certificates from Intellectual Property India
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Gufic BioSciences Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 849.595 659.2153 330.3601 225.1873 241.9697
Liabilities 849.595 659.2153 330.3601 225.1873 241.9697
Equity 10.0278 9.6945 9.6945 9.6945 9.6945
Gross Profit 145.8714 134.6513 145.7147 83.9195 52.1155
Net Profit 86.1356 79.7048 95.8401 44.2316 22.6879
Cash From Operating Activities -7.4571 -26.5872 104.4442 89.0648 47.1018
NPM(%) 10.67 11.54 12.3 9.06 5.98
Revenue 806.6657 690.6208 779.1556 487.6987 378.8374
Expenses 660.7943 555.9695 633.4409 403.7792 326.7219
ROE(%) 15 13.88 16.69 7.7 3.95

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
18 Sep 2024 0.1 10 0.03 321.05
24 Aug 2022 0.1 10 0.03 243.9
09 Sep 2021 0.1 10 0.03 190.7
03 Nov 2020 0.05 5 0.03 102.1
20 Sep 2019 0.05 5 0.03 59.7
0.05 5 0.03 145.55
28 Aug 2017 0.05 5 0.03 66.25
19 Sep 2016 0.05 5 0.03 41.05
22 Sep 2015 0.05 5 0.03 14.05
18 Sep 2014 0.05 5 0.03 20.9
02 Sep 2013 0.05 5 0.03 5.55
16 Aug 2012 0.05 5 0.03 7.75
16 Sep 2011 0.05 5 0.03 6.05
20 Sep 2010 0.05 5 0.03 6.35
17 Sep 2009 0.05 5 0.03 6.35
11 Dec 2008 0.05 5 0.03 4.45
19 Mar 2008 0.05 5 0.03 9.45
20 Sep 2006 0.16 16 0.03 11.7
22 Sep 2005 0.22 22 0.03 29.75

Peers

Other companies within the same industry or sector that are comparable to Gufic BioSciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.15 -0.84 26.88 217.96 301.39 0.62
Lotus Eye Hospital and Institute Ltd 74.06 0.78 308.58 794.21 14.01 0.68
Vaishali Pharma Ltd 12.85 -1.15 428.33 409.37 2.76 0.00
Astec Lifesciences Ltd 701.25 -1.59 0.00 748.87 -687.11 0.00

Company Info

Central Finance Ltd. is a Bombay based company engaged in leasing, bill discounting, loan syndication, merchant banking/advisory services, investments, debt operations, portfolio management scheme, underwriting etc. Central Finance Securities Ltd. is the subsidiary of the company. The company has 100% stake in the subsidiary. 2000 - The Company name of changed to Gufic Biosciences Ltd. 2003 -Forays into vegetables market under the brand 'Gufic seeds'. 2004 -Gufic Biosciences eyes JV in biotech biz 2005 -Gufic Biosciences - Launch of new products 2007 -Gufic Biosciences Ltd has appointed Dr. M C Dhapalapur as Director of the Company on the Board of Directors of the Company with effect from August 01, 2007. 2008 - The Company has set up manufacturing facility for manufacture of Oncology Products. 2012 - The Board of Directors of the Company, inter alia, has recommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2013 -Gufic Biosciences Ltd has irecommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2014 - Ms. Hemal Deasi, Non- Independent Director has been appointed as an Additional Director. -Gufic Biosciences Ltd has recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.

Central Finance Ltd. is a Bombay based company engaged in leasing, bill discounting, loan syndication, merchant banking/advisory services, investments, debt operations, portfolio management scheme, underwriting etc. Central Finance Securities Ltd. is the subsidiary of the company. The company has 100% stake in the subsidiary. 2000 - The Company name of changed to Gufic Biosciences Ltd. 2003 -Forays into vegetables market under the brand 'Gufic seeds'. 2004 -Gufic Biosciences eyes JV in biotech biz 2005 -Gufic Biosciences - Launch of new products 2007 -Gufic Biosciences Ltd has appointed Dr. M C Dhapalapur as Director of the Company on the Board of Directors of the Company with effect from August 01, 2007. 2008 - The Company has set up manufacturing facility for manufacture of Oncology Products. 2012 - The Board of Directors of the Company, inter alia, has recommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2013 -Gufic Biosciences Ltd has irecommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2014 - Ms. Hemal Deasi, Non- Independent Director has been appointed as an Additional Director. -Gufic Biosciences Ltd has recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.

Read More

Parent Organisation

Gufic BioSciences Ltd.

Founded

23/07/1984

Managing Director

Mr.Jayesh P Choksi

NSE Symbol

GUFICBIOEQ

FAQ

The current price of Gufic BioSciences Ltd is ₹ 374.85.

The 52-week high for Gufic BioSciences Ltd is ₹ 390.65 and the 52-week low is ₹ 372.35.

The market capitalization of Gufic BioSciences Ltd is currently ₹ 3758.90. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Gufic BioSciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Gufic BioSciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gufic BioSciences Ltd shares.

The CEO of Gufic BioSciences Ltd is Mr.Jayesh P Choksi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT